As­traZeneca, Io­n­is un­veil full PhI­II da­ta for 'mega brand' AT­TR drug

As­traZeneca and Io­n­is fleshed out a Phase III win for eplon­ter­sen Mon­day morn­ing at this year’s Amer­i­can Acad­e­my of Neu­rol­o­gy meet­ing, il­lus­trat­ing why the pair …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER